Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-24 @ 5:33 PM
Study NCT ID:
NCT04021368
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-14
First Post:
2019-07-12
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Sponsor:
Ryvu Therapeutics SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-12
First Submit QC Date:
None
Study First Post Date:
2019-07-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-13
Last Update Post Date:
2024-02-14
Last Update Post Date Type:
ACTUAL